A review of the handling of missing longitudinal outcome data in clinical trials by Matthew Powney et al.
TRIALS
Powney et al. Trials 2014, 15:237
http://www.trialsjournal.com/content/15/1/237
REVIEW Open Access
A review of the handling of missing
longitudinal outcome data in clinical trials
Matthew Powney*, Paula Williamson, Jamie Kirkham and Ruwanthi Kolamunnage-Dona
Abstract
The aim of this review was to establish the frequency with which trials take into account missingness, and to discover
what methods trialists use for adjustment in randomised controlled trials with longitudinal measurements. Failing to
address the problems that can arise from missing outcome data can result in misleading conclusions. Missing data
should be addressed as a means of a sensitivity analysis of the complete case analysis results. One hundred
publications of randomised controlled trials with longitudinal measurements were selected randomly from trial
publications from the years 2005 to 2012. Information was extracted from these trials, including whether reasons for
dropout were reported, what methods were used for handing the missing data, whether there was any explanation of
the methods for missing data handling, and whether a statistician was involved in the analysis. The main focus of the
review was on missing data post dropout rather than missing interim data. Of all the papers in the study, 9 (9%) had
no missing data. More than half of the papers included in the study failed to make any attempt to explain the reasons
for their choice of missing data handling method. Of the papers with clear missing data handling methods, 44 papers
(50%) used adequate methods of missing data handling, whereas 30 (34%) of the papers used missing data methods
which may not have been appropriate. In the remaining 17 papers (19%), it was difficult to assess the validity of the
methods used. An imputation method was used in 18 papers (20%). Multiple imputation methods were introduced in
1987 and are an efficient way of accounting for missing data in general, and yet only 4 papers used these methods.
Out of the 18 papers which used imputation, only 7 displayed the results as a sensitivity analysis of the complete case
analysis results. 61% of the papers that used an imputation explained the reasons for their chosen method. Just under
a third of the papers made no reference to reasons for missing outcome data. There was little consistency in reporting
of missing data within longitudinal trials.
Keywords: Review, Missing, Data, Handling, Longitudinal, Repeated, Measures
Review
In clinical studies in general, missing data is a problem that
frequently arises [1]. In any given trial, measures are taken
to assure that the level of missingness is as low as possible,
as high percentages of missing data can prove problematic
in establishing the true clinical effectiveness of different
treatments [2]. It can occasionally be difficult to pinpoint
the reasons for missingness after the clinical elements of
a trial have terminated, so there is a benefit to monitoring
the reasons for missing data while the trial is ongoing. The
most accurate estimates of treatment effects within a trial
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can be obtained if we take into account the patients with
missing data values, as well as those who completed the
trial with a full set of outcome data [3]. In order to account
for this missing data in the most appropriate manner, it
is essential to record the reasons for missingness and take
these reasons into account when selecting an appropriate
method of statistical analysis [4].
Missing outcome data in longitudinal and repeated
measures studies can prove particularly problematic, as
organising the collection of multiple data points per
patient can result in higher percentages of missingness.
However, one advantage we have for dealing with the
missing data in longitudinal studies over single read-
ing studies is that we can use previous readings of the
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longitudinal outcome to gain more accurate estimates of
the unknown outcomes. Many methods for missing data
handling have been introduced in the past 30 years includ-
ing modelling techniques which attempt to account for
missing data, such as mixed models and joint modelling
of longitudinal and time-to-event data, and imputation
methods. With these modern developments it is of inter-
est to observe how missing data has been dealt with in
recent clinical trials [5-8].
By reviewing all trials published between July and
September of 2001 in four leading journals, White, Wood
and Thompson came to the conclusion that missing out-
come data was a large problem in clinical trials and that
missing data was ‘often inadequately handled’. Observ-
ing the results from this study, 17 out of the 37 (46%) of
the repeated measures clinical trials analysed used a com-
plete case analysis method for dealing with the missing
data, which excludes patients with any missing values [3].
The majority of papers included in this review did not
have repeated measurements recorded over time. Little
research has been done into how missing data is handled
specifically in clinical trials with longitudinal outcome
data in practice.
One method of dealing with missing data in clinical tri-
als is imputation. Imputation methods can be categorised
as either simple or multiple. Simple methods involve the
imputation of one value and multiple imputation tech-
niques can be used to generate multiple imputed datasets,
the results of which are then pooled to provide estimates
of treatment effect. A poor choice of simple imputation
mechanism can lead to incorrect conclusions about treat-
ment effect [9]. When using a simple imputation, Rubin
[6] was concerned that, while these methods were easy
to employ, they failed to preserve the variability in the
dataset. Multiple imputations are a more flexible method,
as they take into account a greater range of missing data
possibilities and also address the issue of variability [10].
In the aforementioned review by Wood et al., the most
commonly used method of imputation was Last Observa-
tion Carried Forward (LOCF), which was used in 5 out of
37 (13.5%) of the papers [3]. Alternative simple imputa-
tion methods were used in 6 out of 37 (16%), while only 1
out of 37 (2.7%) of the papers with longitudinal readings
in this study used multiple imputation methods.
Establishing the reasons for missingness within a trial
and using appropriate methods based on this informa-
tion is of utmost importance. An appropriate strategy for
imputation within a trial with justification can be put into
action, and the results from this imputed dataset can then
be compared with the results of a complete case analysis.
This would allow the investigator to assess both analy-
ses on their own merits, and draw conclusions from both
estimates. Different conclusions when comparing simple
imputation to the complete cases indicate the data is not
Missing Completely at Random, and similarly different
conclusions with the multiply imputed and complete case
datasets suggest data is Not Missing at Random [9].
As we understand that the need to use as much infor-
mation as possible about missingness within trials is such
an important issue, this will be the main focus of the
paper. Unlike previously published systematic reviews that
focus on missing data, this paper exclusively includes tri-
als which have some form of longitudinal measurements
taken. The review here does not select from specific jour-
nals based on their impact factor in order to provide
the most general results possible within the framework
of randomised controlled trials (RCTs) with longitudinal
measurements.
Methods
The review was conducted in order to gain information
about the frequency and extent to which missing data was
recognised as an issue in trials with longitudinal measure-
ments, and how it was dealt with. We aimed to establish
how often these trialists collect the reasons for missing
data and whether these are reported in the analysis. In
particular, we aimed to ascertain details about the use of
imputation in these trials; whether imputation was used,
and if an explanation for doing so was provided in the text.
One thing which could dictate the need for imputation in
such a study is the percentage of completing patients, as
low percentages of missing data will yield similar conclu-
sions in an imputed dataset as a complete case analysis [2].
In such a case, statisticians or clinicians may be justified
in claiming that missing data methods such as imputa-
tion are not required. We investigated to establish if there
was a relationship between the use of imputation meth-
ods and the percentage of completing patients. Also, it
seems intuitive that papers which have had the benefit of
a statistician’s knowledge of these techniques would have
a more comprehensive analysis and acknowledgement of
the problems provided by missing data; so we aimed to
establish whether there was evidence to support this.
The development of imputation techniques is the sub-
ject of ongoing research within the statistics community.
In this study we wanted to investigate whether there
had been a rise in the use of these methods in the past
few years for studies where dropout occurred, and also
whether these imputed results were presented alongside
the complete case analysis results, as this level of detail can
prove useful to a clinician.
In this study, dropout is defined as a patient having no
more longitudinal readings until the end of the follow-up
period. While the missing data for patients who have not
dropped out is also an issue which can be dealt with in
largely the same way as that for dropouts, the main focus
of our extracted data will be on those individuals who
withdrew from each trial.
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Eligibility criteria
We included papers that were described as a ‘randomised
control trial’ with longitudinal or repeated measurements
taken at some point in the trial. The longitudinal mea-
surements also had to be balanced; this can be defined
as having measurements recorded at the same set time
points for each patient. As we were assessing the recent
use of methods and recent attitudes to missing data in
longitudinal studies, we only included papers that were
published from the years 2005 to 2012, and no restrictions
were put on journal.
All papers that were not written in English or had non-
human participants as the subjects were excluded from
the study, as well as any papers with only binary outcomes
being recorded longitudinally.
Study selection and data extraction
From all the papers identified as eligible for this study,
100 were selected at random due to time constraints. This
randomisation was done by ordering the papers alpha-
betically by first author surname, giving each of these
papers a random number, and then randomly generating
a sequence of the integers using the ‘random’ function
in the R statistical software. The data was then extracted
from each paper in order. If a paper was found to be inel-
igible on closer inspection, then the 101st paper in the
sequence was added to the study, and then the 102nd and
so on. If less than 100 eligible papers were identified, then
all papers were included. To identify potential papers for
inclusion, MEDLINE (Ovid interface) was searched using
the following terms; longitudinal randomi$ed controlled
trial$ or repeated measure$ randomi$ed controlled
trial$ or longitudinal RCT$ or the same searches with
‘controlled’ replaced by ‘control’. The papers identified
also had to fall within the constraints of our prespecified
eligibility criteria.
An extraction form designed to collect all necessary
information was created and verified by the authors listed
within the study. The 100 papers had data extracted by
the first author (MP). The summary of the extracted data
was reviewed by the second and third authors (RKD, JK).
If there were any ambiguities or confusion as to the
extracted data, the second and third authors were
consulted.
For each longitudinal trial, data was extracted relating
to the general characteristics of the trial, as well as more
specifically the details relating to missing data handling.
Our main focus was to look at the missing data handling
methods used for patients that dropped out, as opposed
to just those with missing interim values. Details of the
nature of the longitudinal data, how many time points
there were and whether a primary longitudinal outcome
was recorded, were extracted. We were interested in the
percentage of completing patients within the study, as we
felt that there may be a greater need for imputation-based
methods with larger amounts of missing data, and details
of this were extracted from each trial. The imputation
method used in each study was recorded, as well as the
level of explanation for using the chosen method for miss-
ing data handling and whether each trial recorded reasons
for dropout within a study. We also provided an assess-
ment of whether we felt that the methods for missing
data handling were appropriate in each paper. Whether a
statistician was present as one of the authors of the study,
as well as the software used were also noted. Finally, for
the papers that used imputation we collected information
about whether a comparison was made between the com-
plete case and imputed datasets, as well as whether these
analyses yielded different statistical conclusions.
Data analysis
Counts were made on the number of papers that fall
into each category, as well as cross references between
the different abstracted groups to search for potential
correlations.
Results
Potential papers for inclusion were identified using the
MEDLINE (Ovid interface). A CONSORT diagram of the
progress is included as Figure 1.
A total of 882 hits were obtained from the search strat-
egy. These 882 abstracts were screened for potentially eli-
gible papers, which narrowed down to 381 papers eligible
for inclusion. After a randomisation of the order of these
papers, 10 of the papers we attempted to extract data from
were found to be ineligible due to the unbalanced nature
of their longitudinal readings. Therefore, we read through
110 papers before establishing 100 which were eligible. A
full list of the eligible papers included in the study are
provided in Additional file 1.
Methods of imputation
Data was collected from papers from a wide range of dif-
ferent medical areas in order to investigate how missing
data was handled in practice for randomised control tri-
als with longitudinal measurements. The most popular
medical areas were mental health (13%), cancer (11%) and
rheumatology (10%). Greater detail of the properties of
these trials is provided in Table 1, and Table 2 lists the
primary method of imputation for missing data handling
within the study. Table 3 provides a full list of medical
areas included in the study.
In Table 1, ‘Complete case analysis’ denotes the trials in
which only patients that did not drop out were recorded.
Those papers which would come under the category of
‘Mixed models’ are trials which took into account all
available data, but used no imputation methods, as in
many cases this type of analysis is sufficient for handling
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Figure 1 CONSORT diagram of the systematic review process. A CONSORT diagram describing the process of how many papers were eligible
for inclusion and how many were eliminated after our initial search.
those patients that dropped out. Any papers which did
not use imputation, did not exclude any data but did not
used mixed models fall into the category of ‘Other non-
imputation based methods’. We have listed how many
papers used simple imputation and multiple imputation,
with specific details of the nature of simple imputation
methods underneath this heading.
As presented in Table 1, 9 papers had no missing data
in their trials, and the 3 papers in the ‘Unclear’ cate-
gory made no reference to missing data, and the analy-
sis failed to mention any missingness or clarify whether
or not imputation methods were used. Out of the 100
papers, 18 had used imputation and only 4 had used
multiple imputation as the most advanced missing data
handling method. One paper carried out a complete case
analysis as the primary method of missing data han-
dling, but included an analysis based on LOCF as a
secondary method. For the papers that only included
the complete cases, the most common methods of anal-
ysis were variations of ANOVA or ANCOVA in 13
trials, mixed modelling in 6 trials, t-tests for mean com-
parison in 5 trials and linear regression modelling in
4 trials.
The most common method of simple imputation used
was LOCF or a variation of this method. LOCF was
used in 8 papers. The clinical topics in these papers were
quality of life (QoL) based on moral support in patients
with depression, chronic muscle-based neck pain, chronic
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Table 1 Method of missing data handling
Primary approach to analysis Papers
Complete case analysis 32
Mixed models 18
Simple imputation 141
LOCF/FOCB/Baseline Carried Forward 9
Average value either side Imputed 1
Simple algorithmic-based imputation 1
Mean of other patients values imputed 1
Median values imputed 1
Multiple imputation methods 4
Other non-imputation-based methods2 14
Exclusion based on amounts of missingness 6
Exclusion based on reasons for missingness 1
No missing data 9
Unclear 3
1One paper which used a complete case analysis also used simple imputation as
a secondary analysis. In Table 2, this paper is included in the simple imputation
section.
2Comparison of means, for example, t-test, RMANOVA.
arm pain due to repetitive use, shoulder pain in stroke
patients, outcomes in chronic obstructive pulmonary dis-
ease (COPD), stress levels in arthritic patients, amount
of sleep in patients with chronic insomnia and number
of behavioural disturbances in patients with dementia.
In one trial, the baseline value was carried forward to
impute outcome data at two and six months. LOCF may
be a reasonable method if patients are in a steady state
closer to the time of dropout, therefore the use of LOCF
may be questionable in some of these disease areas such
as stroke and dementia. For those papers that used sim-
ple imputation, as a primary method of analysis 5 trials
used t-tests for comparison of means, 5 used linear mixed
models, 3 used a variation of ANOVA and 1 used the chi-
squared test. Of the trials that used multiple imputation
methods, 2 used mixed modelling, 1 used linear regres-
sion modelling and 1 used t-tests as the primary method
of analysis.
For the remaining results tables, we have excluded the
papers with no missing data and the papers where the
methods were unclear.
Explanation of the reasons for using the statistical
methods for handling missing data
When extracting data with regard to including some
explanation of the statistical methods used for analysing
the missing data, we found that 37 (42.0%) papers with
missing values made comments on why they had used
their particular method of choice. The level of explanation
ranged from one-line statements about the efficiency
of the chosen method, to multiple page descriptions
of different missing data methods and the merits of
each.
Of the papers with data extracted, 51 (58.0%) pro-
vided no explanation of the reasons for the missing data
methods used. All 4 papers that employed multiple impu-
tation methods provided an explanation of the reasons for
their use. Out of the 14 papers that used simple impu-
tation methods, 7 (50%) explained the reasons for their
choice of imputation. A total of 26 out of 70 (37.1%)
papers without imputation attempted to explain the rea-
sons for the missing data handling method chosen. For
the papers with no missing data, 1 of the 9 (11.1%) dis-
cussedmissing data methods within the report, despite no
missing data being presented when the trial was carried
out. This was done with a view to suggesting how they
were going to analyse the missing data should this issue
arise.
Was a statistician involved in the analysis?
It was found that out of the 88 papers with missing
data, 30 (34.1%) had a statistician cited as one of the
co-authors of the study. Results indicated that there
was little difference in the levels of explanation of the
missing data methods used when a statistician was co-
authoring a paper. Out of the 37 papers which justified
their missing data methods, 13 (35.1%) had a statisti-
cian present, compared to 17 out of 51 (33.3%) papers
which failed to explain the reasons for their chosen
method.
Number of publications by year
We aimed to assess whether a greater number of papers
had used imputation in recent years. Figure 2 displays
these results.
All multiple imputation analysed papers were from 2009
onwards, and the majority of simple imputation based
papers were published in the last three years. This could
indicate an increase in a recognition and awareness of
the benefits of using imputation within the past few
years.
When we assessed whether the levels of explanation
given for using the chosen missing data method had
increased in the past few years, as well as the amount of
reasons for missing data reporting, we found that there
was not a substantial increase.
The imputation method used, based on the percentage of
completing patients within the study
With larger percentages of missing data, there is a greater
potential for bias if these non-completing patients are
ignored within the analysis. We present Figure 3 to repre-















Table 2 Trial characteristics
Method of handling missing data Acceptable method?1
No. of papers Complete cases Simple2 Multiple Mixedmodels Nomissing data Unclear Other3 Yes No Unclear
Number of patients 1-100 48 17 8 0 4 8 3 8 18 9 13
101-200 22 8 2 2 5 1 0 4 9 11 1
201-300 12 4 2 0 4 0 0 2 8 4 0
301-400 7 1 1 1 1 0 0 3 3 3 1
400+ 11 1 1 1 4 0 0 4 6 3 2
Country of publication USA 53 20 7 2 10 4 0 10 20 18 11
UK 40 8 6 2 7 3 3 11 20 12 5
Denmark 3 2 0 0 0 1 0 0 2 0 0
Netherlands 3 1 1 0 1 0 0 0 2 0 1
Japan 1 0 0 0 0 1 0 0 0 0 0
Number of time points 3 38 13 4 3 10 1 1 6 14 16 7
4 28 9 4 1 4 2 2 6 14 4 8
5 16 4 3 0 3 2 0 4 10 3 1
6 6 2 0 0 0 2 0 2 1 3 0
7 4 1 0 0 0 2 0 1 1 1 0
8+ 8 2 3 0 1 0 0 2 4 3 1
Year 2005-06 19 9 2 0 1 2 1 4 7 4 6
2007-08 27 8 3 0 5 4 0 7 11 10 2
2009-10 25 7 3 1 4 3 1 6 9 8 5
2011-12 29 7 6 3 8 0 1 4 17 8 4
Clinical area Mental health 13 2 4 2 1 1 1 2 7 2 3
Cancer 11 4 1 1 4 0 1 0 5 4 2
Rheumatology 10 4 1 0 2 1 0 2 3 5 1
Infectious diseases 8 4 1 0 1 1 0 1 4 2 1
Heart and circulation 7 1 2 0 1 0 0 3 3 2 2
Dentistry/oral health 6 3 1 0 0 2 0 0 3 1 0
Neurology 6 2 0 0 2 0 0 2 2 2 2
Anaesthesia and pain 6 3 0 0 1 0 0 2 2 2 2
Other4 33 8 4 1 6 4 1 9 15 10 4
Dropout reasons recorded? Yes 35 (39.8%)5 15 7 0 7 NA NA 6 20 11 4
Partial information 25 (28.4%) 7 5 1 7 NA NA 5 15 9 1
No 28 (31.8%) 10 2 3 4 NA NA 9 9 10 9
1Based on the 91 papers which had missing data.
2One paper which used a complete case analysis also used simple imputation as a secondary analysis. In Table 2, this paper is included in the simple imputation section.
3Comparison of means e.g t-test, RMANOVA.
4A full list of medical areas is included in Table 3.
5Disregarding the 9 papers without missing data and 3 papers where the missing data handling method was unclear.
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Heart and circulation 7
Dentistry/oral health 6
Neurology 6
Anaesthesia and pain control 6
Blood disorders 3
Developmental, psychosocial, and learning problems 2
Endocrine and metabolic 5
Eye and vision 2
Gastroenterology 1
Health care of older people 2
Kidney disease 2
Lungs and airways 2
Neonatal care 2
Orthopaedics and trauma 4




Out of the papers with a clear definition of the
methods for handling missing data, 12 (12.3%) did
not mention the percentage of completing patients.
11 (68.8%) of papers with less than 70% completing
patients used no imputation methods, which could poten-
tially lead to biased results. In general, trials with less
than 10% patients dropping out rarely used imputation
methods.
Were the reasons for dropout recorded?
We assessed the level of information given for dropout
in each study by putting each paper into one of the
following categories. ‘Yes’ is defined as detailed discussion
on missingness or reason for dropout, including a record
of the number of people that dropped out and the specific
reasons for dropout recorded at each time point. ‘Partial
information’ is defined as less detailed with some mention
of the reasons for dropout or missingness, but not neces-
sarily indicating the number of patients at each time point
or providing specific medical reasons. Papers in the ‘No’
category provided no details of the reasons for missing
data.
We can see from Table 2 that 35 (39.8%) of papers fell
into the ‘Yes’ category, providing substantial and detailed
reasons for the missing data of each patient. In 25 (28.4%)
of cases, the details of reasons for dropout could be cate-
gorised as ‘Partial information’. 28 (31.8%) of papers failed
to provide any reasons for patients dropping out.
Where no reasons were recorded for missing data, 7
out of the 28 (25.0%) papers made an attempt to explain
the reasons for the missing data handling method that
was used. For the papers that had some reference to rea-
sons for dropout, 30 out of 60 (50%) made an attempt
to explain the reasons for their chosen method of miss-
ing data handling. However, the majority of these papers
provided justification in terms of the general statistical
benefits of the method used, as opposed to information
relating to the specific prognostic factors and potential
dropout reasons unique to the trial in question.
Figure 2 Number of publications for each imputationmethod by year. A graph displaying the number of publications which used the different
types of imputation method each year.
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Figure 3 Number of publications for each imputation method by percentage of completing patients. A graph displaying the number of
publications which used the different types of imputation based on the percentage of patients who completed their measurement schedule within
the trial.
Assessment of the appropriateness of the missing data
methods used
We looked at the reasons given for the use of each missing
data method within the 100 papers, and assessed whether
we felt that the reasons given provided an adequate justi-
fication for that method.
Of the 37 papers that attempted to explain the reasons
for their chosen missing data method, we felt that 19
(51.3%) had provided sufficient detail and justification for
their choice. For 5 papers, it was unclear whether the jus-
tifications provided were enough, and in 13 (35.1%) of the
cases we felt that the justification provided was insuffi-
cient for the method used. In many of these cases, the
author provided reasons which may have been applica-
ble in certain situations, but failed to acknowledge the
specifics of the trial in question, for example, ‘certain
relatively simple methods can be appropriate’ referring to
a complete case analysis when the trial in question has
a high percentage of missing outcome data. While this
justification may be appropriate in some trials with low
percentages of missing data despite the vagueness of the
explanation, it disregards the fact that the trial in question
had over 30% missing data.
In Table 2, we also provided our own assessment as to
whether the methods used were appropriate, when possi-
ble to determine, in each paper. In 44 (50%) of the papers
with missing data where the methods were clear, we felt
that the method used to handle missing data was appro-
priate, for example, the LOCF method for missing data
being used in a trial where there was a steady state out-
come. It was difficult to determine the appropriateness in
14 (15.9%) of the papers, for example, in trials where the
amount of missing data was not recorded in the paper
and either a complete case or mixed model analysis was
used. In 30 (34.1%) of the papers we felt that the method
used was not appropriate, for example, in a trial with high
percentages of missing data that used a complete case
analysis.
We judged that in all cases where multiple imputation
was used, this was an appropriate method, and only in 2
papers out of 14 (14.3%) was simple imputation deemed
inappropriate. There were 13 (40.6%) which used a com-
plete case analysis where the percentage of missing data
was too high (over 10%) to justify. We concluded that
the majority of papers which used mixed models with-
out imputation as a form of missing data handling were
justified in doing so.
Imputed datasets as a comparison to non-imputed data
Out of the 18 papers that used imputation methods, 11
(61.1%) made no reference to a comparison between the
complete case analysis results and the imputed dataset
results. Of the 7 papers that made the comparison, 2
(28.6%) of them yielded different clinical conclusions
about treatment effect when complete case analysis was
compared to one of the imputed datasets, although one
paper only provided the details of this difference for
the purpose of illustration. One of the 2 papers (men-
tal health) had 43.2% dropout, and reported the P-values
for treatment comparison using the complete case (P =
0.428), mean imputation (P = 0.360), LOCF (P = 0.026),
and multiple imputation (P = 0.426). The treatment effect
was significant when LOCF was used but not when other
imputation methods were used. However, in this case
the authors suggested that LOCF was not an appropri-
ate method to use for missing outcome data in their trial,
and therefore concluded no difference in treatment effect.
This illustrates how an incorrect choice of missing data
handling method can influence the results, and in this
particular case the authors used an appropriate method
in order to gain accurate results. The second study, also in
mental health, stated that there had been a difference in
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conclusion without presenting both sets of results. Both of
these papers had less than 70% of patients completing the
study.
Discussion
The extent of missing data handling and use of imputation
methods
In the CONSORT statement, point 13b. states “for each
group, losses and exclusions after randomisation, together
with reasons” should be included within the trial report
[11]. This was not adhered to in a large number of trials
within the study. It is difficult to suggest a gold stan-
dard for missing data handling, as the appropriateness of
a method is dependent on the unique nature of missing
data within each individual trial. However, by carrying out
a complete case analysis or eliminating certain patients
based on level of missingness or prognostic factor we are
making a bold assumption that the data we exclude is
missing completely at random. This is rarely, if ever, the
case in practice [9]. Therefore, it was disappointing to see
that 39 out of 88 (44.3%) papers that had patients with
missing data excluded records. The 32 out of 88 (36.4%)
papers that carried out a complete case analysis indi-
cates a decrease in the use of this method since the study
by Wood, White and Thompson in 2004 [3]. A greater
understanding of the benefits and methods of multiple
imputation has been developed in recent years. However,
only 4 papers within the study used multiple imputation,
with the evidence suggesting that statisticians are more
frequently using simple imputationmethods. One positive
sign is that the trends suggest that more papers in the past
few years have been using multiple imputation methods.
It was also interesting to discover that having a statistician
involved within a trial investigation did not appear to have
much of an impact on the choice of imputation method or
the level of explanation for such a method being used.
As well as the aim of obtaining an accurate estimate of
clinical outcome, there is a lot to be said for establishing
the properties of the missing data. The goal of imputa-
tion is to create a full dataset with similar properties to
that which would have been observed had no missing
data been present. The use of some simple imputation
methods, such as best/worst case value imputation may
provide us with more extreme results, with a potential for
biased estimates. In many cases, the use of simple impu-
tation methods without a detailed explanation of reasons
can raise as many questions as they answer, and careful
justification should be provided in order to demonstrate
their validity in each individual trial. Within the trials
analysed in this study, half the papers that used simple
imputation within the study justified their reasons for use.
One factor which is prominent in establishing whether
imputation methods may be beneficial is looking at the
amount of missing data and the percentage of patients
dropping out of a trial. The findings of the paper published
by White, Wood and Thompson showed that imputation
was more frequently used in papers with larger amounts
of missing data. In this study, while papers with a lower
percentage of dropouts appeared to be less frequent in
their use of imputation, there was still a large number of
papers with high levels of dropout that did not impute.
In particular, 11 out of the 16 (68.8%) papers with more
than 30% of patients dropping out of the trial used no
imputation methods. This is a potentially worryingly high
figure, as failing to utilise the information provided by
missing data, when there is such a large amount of miss-
ingness, can cause us to draw misleading conclusions. It
has been suggested in the past that trials with over a 15%
dropout rate are in need of the missing data to be analysed
and addressed [2]. Also 30 (33.0%) papers used inappro-
priate missing data handling methods, and 13 (35.1%) of
the papers that attempted to explain the reasons behind
their choice of method provided an inadequate justifica-
tion. For clarity and to provide maximum information,
one suggested technique is to present the imputed dataset
results alongside the results for just complete case anal-
ysis. This was done in 7 out of 18 (38.9%) papers with
imputation methods used. Out of these 7 papers, 2 studies
yielded different conclusions when some of the imputed
results were compared to the complete case; both of these
papers had over 30% dropout. One of the two papers in
particular used a wide range of imputation methods, and
a significant treatment effect was given when LOCF was
used, although LOCF was not selected as an appropriate
missing data handling method in this paper, and the clin-
ical conclusions would have been the same based on the
primary analysis compared with the complete case analy-
sis. This highlights the need to proceed cautiously when
choosing an appropriate missing data handling method.
However, we acknowledge that it may be difficult to assess
the magnitude of this problem from just two papers.
In such a widespread and financial-based industry, the
idea that a clinical trial may provide inaccurate conclu-
sions due to the failure to address missing data is a
worrying thought. We must ask ourselves how we are
going to prevent such an issue from occurring; something
which the findings of this report indicate is failing to be
addressed.
The discussions within this paper have been largely
directed towards appropriate methods of statistical anal-
ysis, with a particular emphasis on the use of imputation.
Missing data becomes less of a problem when we can
obtain larger amounts of information on the patients that
dropped out, as well as minimise the amount of missing
data within a trial. When possible in trials with longitu-
dinal measurements, clinicians and trialists should ensure
that the trial design considers the potential for miss-
ing data arising in the study and aims to take precau-
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tions to try reduce the amount of missingness within a
study.
Guidelines for missing data handling: the four-point plan
The issue of missing data in general (not specific to lon-
gitudinal outcome data) is not dealt with in great detail
in the CONSORT statement. It may be of use to suggest
the following guidelines in order to formalise a procedure
of missing data handling within longitudinal trials. This is
done with the interest of ensuring we are obtaining accu-
rate prognostic conclusions by not failing to recognise the
problems that come with ignoring missing data within a
trial.
• Within a trial the reasons for missing data and, more
specifically, the reasons for dropout, should be
reported in detail. This can be defined as each
individual patient’s reason for dropout being
recorded within the study.
• After assessing these reasons for missingness, there
should be detailed discussions as to the methods that
will be used for missing data handling.
• These methods should then be justified within the
report, and their potential limitations described.
• When the final analysis is carried out, any imputed
dataset results should be presented alongside the
complete case analysis results.
Joint modelling and the MAGNETIC trial
For an example of how missing data could be handled in a
trial, one could point in the direction of the recently pub-
lished MAGNETIC trial [12]. This trial clearly stated its
aims as well as the reasons why patients were dropped
out. Once these reasons were assessed, suitable methods
were chosen and results were presented for the com-
plete case analysis; missing data methods were also used.
One particular method employed in this trial, which was
not used in any of the papers included in this systematic
review, is ‘joint modelling of longitudinal and time-to-
event data’. One benefit of using these joint models is
that they are able to model the longitudinal outcome
over time while accounting for the dropout. Within the
MAGNETIC trial, a complete case analysis failed to show
a difference between a placebo and the magnesium nebu-
liser treatment for reducing the severity of asthma. How-
ever, by employing joint modelling techniques they were
able to establish a statistically significant difference in the
success of the treatments due to the difference in mean
dropout profiles for each treatment group (Figure 4).
By following the example of the MAGNETIC trial, and
the four-point plan that we have proposed, we can ensure
that we do not allow the missing data to be a catalyst for
inaccurate conclusions within randomised control trials
with longitudinal readings.
Limitations
There is always a risk of bias when randomly select-
ing a subset of papers; however, we felt that this was
a more informative method than selecting only papers
from high impact journals. The possibility was consid-
ered that higher impact journals may publish trials with
greater details of missing data. While little research has
been done in to confirm or deny this, not putting a restric-
tion on journal eliminated this potential problem. Should
more time be available, it would be informative to assess
the missing data mechanisms of all 381 papers that were
regarded as eligible.
Conclusions
This study indicates that a large proportion of papers
failed to recognise the issue of missing data, or at best
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Figure 4 Severity score profiles for MAGNETIC. The mean severity score profiles for the patients who dropped out at each time point. The mean
dropout at each time point corresponds to a different colour of line on the graph. The first panel represents the patients that were administered to
Treatment A, and likewise the second panel for Treatment B.
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that an accurate method of missing data handling was
used. The majority of papers failed to explain their rea-
sons for the method of missing data handling employed
within their trial. In addition, less than 40% of papers
gave detailed reasons for the missingness. Collecting the
reasons for missing data can prove a valuable and impor-
tant asset in order to establish the consistency of trials
as well as draw accurate conclusions. Investigators should
use these reasons for missingness in order to establish an
appropriate method for missing data handling, and it is
not necessarily the case that all dropouts within a trial
should be subjected to the same imputation method, if
imputation is used. There was very little consistency in
the levels that the different trials used to consider the
problems caused by missing data. In general, a greater
awareness is needed in order to ensure that clinical inves-
tigators can obtain clinically accurate results from the
trial in question by making informed choices and using
appropriate methods of missing data handling.
Additional file
Additional file 1: Supplementary material. Papers included in the
systematic review. This is a document which lists the 100 papers that were
included within our study.
Abbreviations
CONSORT: Consolidated Standards of Reporting Trials; RCT: randomised
controlled trial.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MP co-developed the protocol, developed the search strategy, carried out the
search and data extraction, and drafted the manuscript as well as providing
final approval of the version to be published. RKD co-developed the protocol,
approved the search strategy, aided with any extracted data ambiguities and
provided comments and assistance for the drafts of the manuscript, as well as
providing final approval of the version to be published. JK co-developed the
protocol, approved the search strategy, aided with any extracted data
ambiguities and contributed to revisions of drafts of the manuscript as well as
providing final approval of the version to be published. PW helped to
conceive the initial idea, and provided comments and assistance throughout
the study on both the extracted data and drafts of the manuscript, as well as
providing final approval of the version to be published.
Acknowledgements
There was no external funding source for this project.
Received: 26 September 2013 Accepted: 22 May 2014
Published: 19 June 2014
References
1. Rubin D: Inference andmissing data. Biometrika 1976, 63(3):581–592.
2. Acuna E, Caroline R: The treatment of missing values and its effect on classifier
accuracy. Classification, Clustering, and DataMining Applications. Berlin
Heidelberg: Springer; 2004. 639–647.
3. Wood AM, White IR, Thompson SG: Are missing outcome data
adequately handled? A review of published randomized controlled
trials in major medical journals. Clin Trials 2004, 1(4):368–376.
4. Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood
AM, Carpenter JR:Multiple imputation for missing data in
epidemiological and clinical research: potential and pitfalls.
BMJ: British Med J 2009, 338:b2393.
5. Hedeker D, Gibbons RD:Missing data in longitudinal studies. Longitudinal
Data Analysis. New York, USA: John Wiley & Sons; 2006. 279–312.
6. Rubin D:Multiple imputation for nonresponse in surveys. New York, USA:
John Wiley & Sons; 1987.
7. Schafer JL: Analysis of incomplete multivariate data. London, UK: Chapman &
Hall; 1997.
8. Van Buuren S, Oudshoorn K: Flexible multivariate imputation by MICE.
Leiden, The Netherlands: TNO Prevention Center; 1999.
9. Carpenter JR, Kenward M:Missing data in clinical trials - a practical guide.
Birmingham, UK: National Institute for Health Research, Publication
RM03/JH17/MK; 2008.
10. McCleary L: Using multiple imputation for analysis of incomplete
data in clinical research. Nurs Res 2002, 51(5):339–343.
11. Schulz KF, Altman DG, Moher D, CONSORT Group: CONSORT 2010
Statement: updated guidelines for reporting parallel group
randomised trials. BMCMedicine 2010, 8:18.
12. Powell C, Kolamunnage-Dona R, Lowe J, Boland A, Petrou S, Doull I,
Hood K, Williamson P:Magnesium sulphate in acute severe asthma in
children (MAGNETIC): a randomised, placebo-controlled trial.
Lancet Respir Med 2013, 1(4):301–308.
doi:10.1186/1745-6215-15-237
Cite this article as: Powney et al.: A review of the handling of missing
longitudinal outcome data in clinical trials. Trials 2014 15:237.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
